A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living ...
Vir Biotechnology, Inc. today announced that tobevibart and elebsiran have received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation and European Medicines Agency (EMA) ...